Provided herein are amorphous and crystalline hemisulfate salt forms of the formula..Also provided are pharmaceutical compositions comprising the amorphous and crystalline hemisulfate salt forms, methods for their manufacture, and uses thereof for treating conditions associated with pyruvate kinase such as e.g., pyruvate kinase deficiency.本文提供下式之非晶形及結晶半硫酸鹽形式。。亦提供包含該等非晶形及結晶半硫酸鹽形式之醫藥組合物、其製造方法及其用於治療與丙酮酸鹽激酶相關之病況，諸如丙酮酸鹽激酶缺乏症的用途。
